LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-30
Case ID: NM_001370466.1_c.2938dup_20261030_201532
Framework: ACMG/AMP 2015
Variant classification summary

NM_001370466.1:c.2938dup

NOD2  · NP_001357395.1:p.(Leu980ProfsTer2)  · NM_001370466.1
GRCh37: chr16:50763778 G>GC  ·  GRCh38: chr16:50729867 G>GC
Gene: NOD2 Transcript: NM_001370466.1
Final call
Pathogenic
PVS1 strong PS4 strong
All criteria require review: For research and educational purposes only.
Gene
NOD2
Transcript
NM_001370466.1
Protein
NP_001357395.1:p.(Leu980ProfsTer2)
gnomAD AF
0.01813616036836422 (v4.1)
ClinVar
Uncertain significance
OncoKB
Interpretation summary
Generated evidence synthesis
1
Pathogenic: PVS1 strong reflects the NOD2 p.(L980Pfs*2) loss-of-function frameshift after the NMD-escape downgrade.
2
Pathogenic: PS4 strong reflects a homozygous Crohn disease genotype relative risk of 42.1 with a confidence interval excluding 1.
Final determination: Under the generic ACMG/AMP 2015 fallback, two strong pathogenic criteria (PVS1 strong and PS4 strong) support a Pathogenic classification.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met at strong: the p.(L980Pfs*2) frameshift has a stop 32 nucleotides before the exon-11/exon-12 junction, triggering the NMD-escape downgrade.
pvs1_generic_framework PMID:25741868
PS1 N/A Not applicable: PS1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: no documented de novo occurrence with confirmed maternity and paternity is available for NM_001370466.1:c.2938dup.
PS3 Not assessed Not assessed: available functional assays studied different NOD2 variants, and no direct validated assay result for c.2938dup (p.(Leu980ProfsTer2)) was identified.
PMID:11425413 PMID:12673278 PMID:15024686 PMID:22684479
PS4 Met Met: homozygous genotype relative risk 42.1 with 95% CI 4.3–infinity exceeds the PS4 >5 threshold and excludes 1 in Crohn disease cases versus controls.
PMID:11425413 clinvar gnomad_v4
PM1 N/A Not applicable: PM1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM2 Not met Not met: observed control frequencies are 0.0146597–0.0181362, far above the <=0.0001 PM2 threshold.
gnomad_v2 gnomad_v4 PMID:25741868
PM3 Not assessed Not assessed: no parent or offspring testing establishes c.2938dup in trans with a pathogenic allele in a recessive disorder.
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 N/A Not applicable: PM5 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM6 Not assessed Not assessed: no apparently de novo occurrence without confirmed maternity and paternity is documented for this variant.
PP1 Not assessed Not assessed: zero informative affected-relative meioses or exact-variant segregation results are documented for NM_001370466.1:c.2938dup.
PMID:12673278 PMID:15024686
PP2 N/A Not applicable: PP2 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PP3 N/A Not applicable: c.2938dup is a frameshift (p.L980Pfs*2), outside PP3's missense or intronic/splice-region scope.
spliceai
PP4 Not assessed Not assessed: the patient's phenotype and family history are insufficient to establish a highly specific phenotype for a single genetic etiology.
PP5 Not met Not met: ClinVar reports zero expert-panel submissions, so conflicting laboratory and aggregate classifications cannot trigger PP5.
clinvar
BA1 Not met Not met: required grpmax FAF values are 0.02141027–0.0239652, all below the 0.05 BA1 threshold.
gnomad_v2 gnomad_v4 PMID:25741868
BS1 Not assessed Not assessed: grpmax FAF is 0.02141027, but reduced/incomplete penetrance and missing maximum-credible-frequency inputs prevent using the 1% default alone.
gnomad_v2 gnomad_v4 PMID:25741868
BS2 Not assessed Not assessed: gnomAD reports 28–607 homozygotes, but healthy-adult status and full early-age penetrance are not established.
gnomad_v2 gnomad_v4 PMID:25741868
BS3 Not assessed Not assessed: no direct validated assay showed normal protein function or splicing for NOD2 c.2938dup (p.(Leu980ProfsTer2)).
PMID:11425413 PMID:12673278 PMID:15024686 PMID:22684479
BS4 Not assessed Not assessed: no affected relatives with documented genotypes are available to demonstrate lack of segregation for this variant.
BP1 N/A Not applicable: BP1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
BP2 Not assessed Not assessed: no family-level phase data show c.2938dup in trans with a dominant pathogenic allele or in cis with any pathogenic allele.
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 N/A Not applicable: c.2938dup is a frameshift (p.L980Pfs*2), so SpliceAI max delta 0.055 cannot support BP4.
spliceai
BP5 Not assessed Not assessed: no patient-level evidence identifies an alternate molecular basis for the disease in a case carrying this variant.
BP6 Not met Not met: ClinVar reports zero expert-panel submissions, so ordinary laboratory benign assertions cannot trigger BP6.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a frameshift variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.